Skip to main content
Erschienen in: Allergo Journal 7/2019

04.11.2019 | Original

Atopic eczema score of emotional consequences — a questionnaire to assess emotional consequences of atopic eczema

verfasst von: Bernd W. M. Arents, Ute Mensing, Irmtraud A. Seitz, Niels Wettemann, Antje-H. Fink-Wagner, Giuseppe de Carlo, Alexander Zink, Prof. Dr. Dr. Johannes Ring

Erschienen in: Allergo Journal | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Atopic eczema (AE, atopic dermatitis), one of the most common chronic skin diseases worldwide, can dramatically influence the lives of affected patients as well as the lives of their families. Despite the availability of several questionnaires for assessing the impairment of quality of life, so far the emotional consequences of AE have received limited attention. The purpose therefore was to develop an instrument to assess the emotional consequences of AE in affected adults.

Methods

The Atopic Eczema Score of Emotional Consequences (AESEC) was developed based on a review of available instruments and by consulting individuals with AE about the emotional consequences of AE through social media. Validation was performed in a test-sample, followed by a large cross-sectional study in patients with AE across nine European countries. AESEC results were compared with the Patient Oriented Eczema Measure (POEM), the Dermatology Life Quality Index (DLQI) and the Hospital Anxiety and Depression Scale (HADS).

Results

A 28-item questionnaire on emotional consequences of having AE was developed. Applied to 1,189 participants, AESEC showed high reliability and correlated well with DLQI, HADS and POEM. More than half (57 %) of the respondents were emotionally burdened. Large to very large emotional consequences were reported by 43.8 % of those with currently moderate AE, 62.2 % with severe AE and 66.7 % with very severe AE-symptoms.

Conclusion

AESEC is a questionnaire for assessing the emotional consequences of living with AE. It may prove useful in evaluating the burden of disease, beyond skin symptoms and time-specific quality of life.
Literatur
1.
2.
Zurück zum Zitat Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy 2018;73:1284–93CrossRef Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy 2018;73:1284–93CrossRef
3.
Zurück zum Zitat Ring J, Ruzicka Th, Przybilla B, editors. Handbook of atopic eczema. BerlinNewYork: Springer; 2006 Ring J, Ruzicka Th, Przybilla B, editors. Handbook of atopic eczema. BerlinNewYork: Springer; 2006
4.
Zurück zum Zitat Sampogna F, Finlay AY, Salek SS, Chernyshov P, Dalgard FJ, Evers AWM, et al. Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instruments. J Eur Acad Dermatol Venereol. 2017;31:1429–39CrossRef Sampogna F, Finlay AY, Salek SS, Chernyshov P, Dalgard FJ, Evers AWM, et al. Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instruments. J Eur Acad Dermatol Venereol. 2017;31:1429–39CrossRef
5.
Zurück zum Zitat Drucker AM,Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the national eczema association. J Invest Dermatol. 2017;137:26–30CrossRef Drucker AM,Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the national eczema association. J Invest Dermatol. 2017;137:26–30CrossRef
6.
Zurück zum Zitat Ring J. Atopic dermatitis—eczema. Berlin New York: Springer; 2016 Ring J. Atopic dermatitis—eczema. Berlin New York: Springer; 2016
7.
Zurück zum Zitat Nørreslet LB, Ebbehøj NE, Ellekilde BJP, Thomsen SF, Agner T. The impact of atopic dermatitis on worklife—a systematic review. J Eur Acad Dermatol Venereol 2018;32:23–38CrossRef Nørreslet LB, Ebbehøj NE, Ellekilde BJP, Thomsen SF, Agner T. The impact of atopic dermatitis on worklife—a systematic review. J Eur Acad Dermatol Venereol 2018;32:23–38CrossRef
8.
Zurück zum Zitat Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient-burden and quality of life in atopic dermatitis in US adults: a population based cross-sectional study. Ann Allergy Asthma Immunol 2018;3:340–7CrossRef Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient-burden and quality of life in atopic dermatitis in US adults: a population based cross-sectional study. Ann Allergy Asthma Immunol 2018;3:340–7CrossRef
9.
Zurück zum Zitat Steinke S, Beikert FC, Langenbruch A, Fölster-Holst R, Ring J, Schmitt J, et al. Measurement of healthcare quality in atopic dermatitis — development and application of a set of quality indicators. J Eur Acad Dermatol Venereol 2018;12:2237–2243CrossRef Steinke S, Beikert FC, Langenbruch A, Fölster-Holst R, Ring J, Schmitt J, et al. Measurement of healthcare quality in atopic dermatitis — development and application of a set of quality indicators. J Eur Acad Dermatol Venereol 2018;12:2237–2243CrossRef
10.
Zurück zum Zitat Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol 2013;131:428–33CrossRef Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol 2013;131:428–33CrossRef
11.
Zurück zum Zitat Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210–6CrossRef Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210–6CrossRef
12.
Zurück zum Zitat Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997;133:1433–40CrossRef Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997;133:1433–40CrossRef
13.
Zurück zum Zitat Whalley D, McKenna SP, Dewar AL, Erdman RA, Kohlmann T, Niero M, et al. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol. 2004;150:274–83CrossRef Whalley D, McKenna SP, Dewar AL, Erdman RA, Kohlmann T, Niero M, et al. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol. 2004;150:274–83CrossRef
14.
Zurück zum Zitat Kiebert G, Sorensen SV, Revicki D, Fagan SC, Doyle JJ, Cohen J, et al. Atopic dermatitis is associated with a decrement in health-relatedqualityoflife. Int J Dermatol 2002;41:151–8CrossRef Kiebert G, Sorensen SV, Revicki D, Fagan SC, Doyle JJ, Cohen J, et al. Atopic dermatitis is associated with a decrement in health-relatedqualityoflife. Int J Dermatol 2002;41:151–8CrossRef
15.
Zurück zum Zitat Warschburger P, Buchholz HT, Petermann F. Psychological adjustment in parents of young children with atopic dermatitis: which factors predict parental quality of life? Br J Dermatol 2004;150:304–11CrossRef Warschburger P, Buchholz HT, Petermann F. Psychological adjustment in parents of young children with atopic dermatitis: which factors predict parental quality of life? Br J Dermatol 2004;150:304–11CrossRef
16.
Zurück zum Zitat Lee SH, Lee SH, Lee SY, Lee B, Lee SH, Park YL. Psychological health status and health-related quality of life in adults with atopic dermatitis: a nationwide cross-sectional study in South Korea. Acta Derm Venereol 2018;98:89–97CrossRef Lee SH, Lee SH, Lee SY, Lee B, Lee SH, Park YL. Psychological health status and health-related quality of life in adults with atopic dermatitis: a nationwide cross-sectional study in South Korea. Acta Derm Venereol 2018;98:89–97CrossRef
17.
Zurück zum Zitat Thyssen JP, Hamann CR, Linneberg A, Dantoft TM, Skov L, Gislason GH, et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide. Allergy 2018;73:214–20CrossRef Thyssen JP, Hamann CR, Linneberg A, Dantoft TM, Skov L, Gislason GH, et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide. Allergy 2018;73:214–20CrossRef
18.
Zurück zum Zitat Dieris-Hirche J, Gieler U, Kupfer JP, Milch WE. Suicidal ideation, anxiety and depression in adult patients with atopic dermatitis. Hautarzt 2009;60:641–6CrossRef Dieris-Hirche J, Gieler U, Kupfer JP, Milch WE. Suicidal ideation, anxiety and depression in adult patients with atopic dermatitis. Hautarzt 2009;60:641–6CrossRef
19.
Zurück zum Zitat Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults andchildren: part I. J Eur Acad Dermatol Venereol 2018;32:657–82CrossRef Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults andchildren: part I. J Eur Acad Dermatol Venereol 2018;32:657–82CrossRef
20.
Zurück zum Zitat Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol 2018;32:850–78CrossRef Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol 2018;32:850–78CrossRef
21.
Zurück zum Zitat Pärna E,Aluoja A,Kingo K.Quality of life and emotional state in chronic skin disease. Acta Derm Venereol 2015;95:312–6 Pärna E,Aluoja A,Kingo K.Quality of life and emotional state in chronic skin disease. Acta Derm Venereol 2015;95:312–6
22.
Zurück zum Zitat Dieris-Hirche J,Gieler U, Petrak F, Milch W, TeWildt B, Dieris B, et al. Suicidal ideation in adult patients with atopic dermatitis: a German cross-sectional study. Acta Derm Venereol 2017;97:1189–95CrossRef Dieris-Hirche J,Gieler U, Petrak F, Milch W, TeWildt B, Dieris B, et al. Suicidal ideation in adult patients with atopic dermatitis: a German cross-sectional study. Acta Derm Venereol 2017;97:1189–95CrossRef
23.
Zurück zum Zitat Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70CrossRef Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70CrossRef
24.
Zurück zum Zitat Ring J, Zink A, Arents BWM, Seitz IA, Mensing U, Schielein MC, et al. Atopic eczema: burden of disease and individual suffering — results from a large EU-study in adults. J Eur Acad Dermatol Venereol 2019;2019;33: 1331–40CrossRef Ring J, Zink A, Arents BWM, Seitz IA, Mensing U, Schielein MC, et al. Atopic eczema: burden of disease and individual suffering — results from a large EU-study in adults. J Eur Acad Dermatol Venereol 2019;2019;33: 1331–40CrossRef
25.
Zurück zum Zitat Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’perspective. Arch Dermatol 2004;140:1513–9CrossRef Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’perspective. Arch Dermatol 2004;140:1513–9CrossRef
26.
Zurück zum Zitat Spuls PI, Gerbens LA, Simpson E, Apfelbacher CJ, Chalmers JR, Thomas KS, et al. POEM a core instrument to measure symptoms in clinical trials: a HOME statement. Br J Dermatol. 2017;4:979–84CrossRef Spuls PI, Gerbens LA, Simpson E, Apfelbacher CJ, Chalmers JR, Thomas KS, et al. POEM a core instrument to measure symptoms in clinical trials: a HOME statement. Br J Dermatol. 2017;4:979–84CrossRef
27.
Zurück zum Zitat Charman CR, Venn AJ, Ravenscroft JC, Williams HC. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol 2013;6:1326–32CrossRef Charman CR, Venn AJ, Ravenscroft JC, Williams HC. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol 2013;6:1326–32CrossRef
28.
Zurück zum Zitat Lauffer F, Ring J. Target-oriented therapy: emerging drugs for atopic dermatitis. Expert Opin Emerg Drugs 2016;21:81–9CrossRef Lauffer F, Ring J. Target-oriented therapy: emerging drugs for atopic dermatitis. Expert Opin Emerg Drugs 2016;21:81–9CrossRef
29.
Zurück zum Zitat Zink A, Gensbaur A, Zirbs M, Seifert F, Suarez IL, Mourantchanian V, et al. Targeting IgE in severe atopic dermatitis with a combination of Immunoadsorption and Omalizumab. Acta Derm Venereol 2016;96:72–6CrossRef Zink A, Gensbaur A, Zirbs M, Seifert F, Suarez IL, Mourantchanian V, et al. Targeting IgE in severe atopic dermatitis with a combination of Immunoadsorption and Omalizumab. Acta Derm Venereol 2016;96:72–6CrossRef
30.
Zurück zum Zitat Ruiz-Villaverde R, Dominguez-Cruz J, Armario-Hita JC, Martinez-Pilar L, Alcantara-Luna S, Dupilumab P-RJJ. Short-term effectiveness and security in real clinical practice. A retrospective multicentric study. J Eur Acad Dermatol Venereol 2019;1:e21–2CrossRef Ruiz-Villaverde R, Dominguez-Cruz J, Armario-Hita JC, Martinez-Pilar L, Alcantara-Luna S, Dupilumab P-RJJ. Short-term effectiveness and security in real clinical practice. A retrospective multicentric study. J Eur Acad Dermatol Venereol 2019;1:e21–2CrossRef
31.
Zurück zum Zitat Bieber T, D’Erme AM, Akdis CA, Traidl-Hoffmann C, Lauener R, Schäppi G, et al. Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go? J Allergy Clin Immunol. 2017;139:58–64CrossRef Bieber T, D’Erme AM, Akdis CA, Traidl-Hoffmann C, Lauener R, Schäppi G, et al. Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go? J Allergy Clin Immunol. 2017;139:58–64CrossRef
32.
Zurück zum Zitat Scheerer C, Eyerich K. Pathogenesis of atopic dermatitis. Hautarzt 2018;69:191–6CrossRef Scheerer C, Eyerich K. Pathogenesis of atopic dermatitis. Hautarzt 2018;69:191–6CrossRef
33.
Zurück zum Zitat Subramanian I, Singh VK, Jere A. Elucidating mechanistic insights into drug action for atopic dermatitis: a systems biology approach. Bmc Dermatol. 2018;18:3CrossRef Subramanian I, Singh VK, Jere A. Elucidating mechanistic insights into drug action for atopic dermatitis: a systems biology approach. Bmc Dermatol. 2018;18:3CrossRef
34.
Zurück zum Zitat Werfel T, Wollenberg A, Pumnea T, Heratizadeh A. New aspects in systemic treatment of atopic dermatitis. Hautarzt 2018;69:217–24CrossRef Werfel T, Wollenberg A, Pumnea T, Heratizadeh A. New aspects in systemic treatment of atopic dermatitis. Hautarzt 2018;69:217–24CrossRef
35.
Zurück zum Zitat Schielein MC, Tizek L, Rotter M, Konstantinow A, Biedermann T, Zink A. Guideline-compliant prescription of biologicals and possible barriers in dermatological practicesin Bavaria. J Eur Acad Dermatol Venereol 2018;32:978–84CrossRef Schielein MC, Tizek L, Rotter M, Konstantinow A, Biedermann T, Zink A. Guideline-compliant prescription of biologicals and possible barriers in dermatological practicesin Bavaria. J Eur Acad Dermatol Venereol 2018;32:978–84CrossRef
36.
Zurück zum Zitat Heratizadeh A, Werfel T, Gieler U, Kupfer J. Arbeitsgemeinschaft Neurodermitisschulung für Erwachsene (ARNE). [Patient education for adults with atopic dermatitis according to theARNEconcept]. Hautarzt 2018;69:225–31CrossRef Heratizadeh A, Werfel T, Gieler U, Kupfer J. Arbeitsgemeinschaft Neurodermitisschulung für Erwachsene (ARNE). [Patient education for adults with atopic dermatitis according to theARNEconcept]. Hautarzt 2018;69:225–31CrossRef
37.
Zurück zum Zitat Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006;60:984–92CrossRef Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006;60:984–92CrossRef
39.
Zurück zum Zitat Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol. 2005;4:659–64CrossRef Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol. 2005;4:659–64CrossRef
Metadaten
Titel
Atopic eczema score of emotional consequences — a questionnaire to assess emotional consequences of atopic eczema
verfasst von
Bernd W. M. Arents
Ute Mensing
Irmtraud A. Seitz
Niels Wettemann
Antje-H. Fink-Wagner
Giuseppe de Carlo
Alexander Zink
Prof. Dr. Dr. Johannes Ring
Publikationsdatum
04.11.2019
Verlag
Springer Medizin
Erschienen in
Allergo Journal / Ausgabe 7/2019
Print ISSN: 0941-8849
Elektronische ISSN: 2195-6405
DOI
https://doi.org/10.1007/s15007-019-1952-4

Weitere Artikel der Ausgabe 7/2019

Allergo Journal 7/2019 Zur Ausgabe

AeDA/DGAKI informieren

Preisverleihungen 2019

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

HNO-Op. auch mit über 90?

16.04.2024 HNO-Chirurgie Nachrichten

Mit Blick auf das Risiko für Komplikationen nach elektiven Eingriffen im HNO-Bereich scheint das Alter der Patienten kein ausschlaggebender Faktor zu sein. Entscheidend ist offenbar, wie fit die Betroffenen tatsächlich sind.

Intrakapsuläre Tonsillektomie gewinnt an Boden

16.04.2024 Tonsillektomie Nachrichten

Gegenüber der vollständigen Entfernung der Gaumenmandeln hat die intrakapsuläre Tonsillektomie einige Vorteile, wie HNO-Fachleute aus den USA hervorheben. Sie haben die aktuelle Literatur zu dem Verfahren gesichtet.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.